NEW YORK (GenomeWeb News) – An array-based analysis by researchers from Australia and elsewhere has identified a gene that is often missing in ovarian cancers that become resistant to liposomal doxorubicin chemotherapy, hinting that it may serve as a marker for such acquired resistance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.